Published in Am J Physiol Heart Circ Physiol on September 17, 2010
AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats. Am J Hypertens (2013) 1.65
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. Hypertension (2012) 0.95
Introgression of the Brown Norway renin allele onto the Dahl salt-sensitive genetic background increases Cu/Zn SOD expression in cerebral arteries. Am J Hypertens (2011) 0.93
Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat. Clin Sci (Lond) (2013) 0.86
Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression. Am J Hypertens (2013) 0.84
Introgression of Brown Norway CYP4A genes on to the Dahl salt-sensitive background restores vascular function in SS-5(BN) consomic rats. Clin Sci (Lond) (2013) 0.82
Congenic mapping and sequence analysis of the Renin locus. Hypertension (2013) 0.80
Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability. Microcirculation (2015) 0.80
Short-term hypercaloric diet induces blunted aortic vasoconstriction and enhanced vasorelaxation via increased nitric oxide synthase 3 activity and expression in Dahl salt-sensitive rats. Acta Physiol (Oxf) (2012) 0.78
Role of vascular reactive oxygen species in regulating cytochrome P450-4A enzyme expression in Dahl salt-sensitive rats. Microcirculation (2016) 0.77
Enhancement of resting-state fcMRI networks by prior sensory stimulation. Brain Connect (2014) 0.75
Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12. Am J Physiol Heart Circ Physiol (2014) 0.75
Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase. Am J Physiol Heart Circ Physiol (2013) 0.75
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 8.57
Prognostic value of coronary vascular endothelial dysfunction. Circulation (2002) 7.68
The clinical implications of endothelial dysfunction. J Am Coll Cardiol (2003) 6.71
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med (1993) 6.45
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest (1996) 6.38
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation (2000) 6.13
Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation (2001) 5.87
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation (2001) 3.14
Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension (2001) 3.00
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res (2002) 2.56
Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) (2007) 2.39
Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension (2001) 1.99
The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth. Arterioscler Thromb Vasc Biol (2007) 1.85
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal (2002) 1.64
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics (2007) 1.57
Consomic rat model systems for physiological genomics. Acta Physiol Scand (2004) 1.50
Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res (2007) 1.36
Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol (2000) 1.35
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation (2001) 1.34
A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science (1989) 1.28
Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension (2008) 1.27
Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol (2006) 1.25
Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension (2001) 1.19
High-salt diet impairs vascular relaxation mechanisms in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol (2002) 1.19
Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr (2008) 1.17
Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol (2003) 1.17
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation (2000) 1.14
Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics (2003) 1.14
Effect of high-salt diet on NO release and superoxide production in rat aorta. Am J Physiol Heart Circ Physiol (2003) 1.13
Renin gene transfer restores angiogenesis and vascular endothelial growth factor expression in Dahl S rats. Hypertension (2001) 1.11
Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet. Hypertension (2005) 1.10
Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am J Physiol Heart Circ Physiol (2006) 1.10
Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet. Microcirculation (2009) 1.07
Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation. Am J Physiol Heart Circ Physiol (2004) 1.06
Elevated salt intake impairs dilation of rat skeletal muscle resistance arteries via ANG II suppression. Am J Physiol Heart Circ Physiol (2000) 1.05
Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension (1993) 1.03
Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol (2001) 1.03
Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension (1995) 1.01
Effect of a high salt diet on microvascular antioxidant enzymes. J Vasc Res (2002) 1.00
Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol Heart Circ Physiol (2002) 0.98
Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2. Am J Physiol Heart Circ Physiol (2009) 0.98
A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol (2000) 0.97
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol (2002) 0.92
Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol Genomics (2008) 0.92
Salt sensitivity is associated with an increased mortality in both normal and hypertensive humans. J Clin Hypertens (Greenwich) (2002) 0.92
Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens (1997) 0.90
Chromosomal substitution-dependent differences in cardiovascular responses to sodium pentobarbital. Anesth Analg (2006) 0.89
Transfer of a salt-resistant renin allele raises blood pressure in Dahl salt-sensitive rats. Hypertension (1997) 0.89
Effects of age and sex on sodium chloride sensitivity: association with plasma renin activity. Clin Nephrol (1994) 0.89
Chronic At1 receptor blockade alters the mechanisms mediating hypoxic dilation in middle cerebral arteries. J Cardiovasc Pharmacol (2005) 0.88
Endothelial dysfunction: the role and impact of the renin-angiotensin system. Heart (2000) 0.87
Chronic captopril administration decreases vasodilator responses in skeletal muscle arterioles. Am J Hypertens (1999) 0.84
Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin. J Am Coll Cardiol (1999) 0.81
Short-term angiotensin converting enzyme inhibition reduces basal tone and dilator reactivity in skeletal muscle arterioles. Am J Hypertens (2000) 0.80
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients. J Clin Hypertens (Greenwich) (2005) 0.80
Pharmacologic management of systemic hypertension in blacks. Am J Cardiol (1988) 0.79
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med (2014) 6.73
Progress and prospects in rat genetics: a community view. Nat Genet (2008) 6.01
Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol (2007) 3.07
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood (2006) 2.77
MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res (2008) 2.51
Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens (2003) 2.35
Physiogenomic resources for rat models of heart, lung and blood disorders. Nat Genet (2006) 2.05
Assessing unmodified 70-mer oligonucleotide probe performance on glass-slide microarrays. Genome Biol (2003) 1.94
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood (2009) 1.89
AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats. Am J Hypertens (2013) 1.65
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics (2007) 1.57
Low cost, scalable proteomics data analysis using Amazon's cloud computing services and open source search algorithms. J Proteome Res (2009) 1.53
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Blood (2009) 1.51
Analyzing complex traits with congenic strains. Mamm Genome (2010) 1.43
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 1.43
MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res (2010) 1.42
ZoomQuant: an application for the quantitation of stable isotope labeled peptides. J Am Soc Mass Spectrom (2005) 1.41
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia. Blood (2009) 1.40
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood (2004) 1.39
Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol (2008) 1.37
Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studies. Pharmacogenetics (2002) 1.37
Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol (2003) 1.37
Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics (2003) 1.37
Impact of genomics on research in the rat. Genome Res (2005) 1.37
Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res (2007) 1.36
Gene targeting in the rat: advances and opportunities. Trends Genet (2010) 1.25
Identifying multiple causative genes at a single GWAS locus. Genome Res (2013) 1.25
Novel role of fumarate metabolism in dahl-salt sensitive hypertension. Hypertension (2009) 1.25
Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Am J Physiol Renal Physiol (2007) 1.24
Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol (2005) 1.21
Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats. Physiol Genomics (2008) 1.21
Renal regional proteomes in young Dahl salt-sensitive rats. Hypertension (2008) 1.20
Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats. Physiol Genomics (2004) 1.15
Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica (2011) 1.14
Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics (2003) 1.14
Effect of high-salt diet on NO release and superoxide production in rat aorta. Am J Physiol Heart Circ Physiol (2003) 1.13
Improved method for the analysis of membrane proteins by mass spectrometry. Physiol Genomics (2007) 1.13
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors. Eur J Immunol (2006) 1.13
CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol (2003) 1.12
Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J Appl Physiol (1985) (2005) 1.12
Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet. Hypertension (2005) 1.10
Computational modeling of physiological systems. Physiol Genomics (2005) 1.10
Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am J Physiol Heart Circ Physiol (2006) 1.10
Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics (2002) 1.10
RF-2 gene modulates proteinuria and albuminuria independently of changes in glomerular permeability in the fawn-hooded hypertensive rat. J Am Soc Nephrol (2005) 1.09
BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol Genomics (2006) 1.09
Creation and characterization of a renin knockout rat. Hypertension (2011) 1.09
How I treat refractory CLL. Blood (2005) 1.08
Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol (2005) 1.07
Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. J Clin Oncol (2007) 1.07
Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet. Microcirculation (2009) 1.07
Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J (2012) 1.07
Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol (2010) 1.06
Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights. Mol Cell Proteomics (2006) 1.06
Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation. Am J Physiol Heart Circ Physiol (2004) 1.06
Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics (2009) 1.06
Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury. Am J Physiol Renal Physiol (2008) 1.06
Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One (2013) 1.05
Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J Am Soc Nephrol (2013) 1.04
Simultaneous quantification and identification using 18O labeling with an ion trap mass spectrometer and the analysis software application "ZoomQuant". J Am Soc Mass Spectrom (2005) 1.01
Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol (2011) 1.01
Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet. Am J Physiol Heart Circ Physiol (2006) 1.01
Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 1.00
Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat. Physiol Genomics (2012) 0.99
Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive rats. Am J Physiol Renal Physiol (2005) 0.98
Rab38 modulates proteinuria in model of hypertension-associated renal disease. J Am Soc Nephrol (2013) 0.98
Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment. Br J Haematol (2011) 0.98
Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2. Am J Physiol Heart Circ Physiol (2009) 0.98
Quantitative assessment of the importance of dye switching and biological replication in cDNA microarray studies. Physiol Genomics (2003) 0.97
Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol (2002) 0.97
18O labeling over a coffee break: a rapid strategy for quantitative proteomics. J Proteome Res (2008) 0.95
Restoration of normal vascular relaxation mechanisms in cerebral arteries by chromosomal substitution in consomic SS.13BN rats. Am J Physiol Heart Circ Physiol (2005) 0.95
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. Hypertension (2012) 0.95
Isolation of signal transduction complexes using biotin and crosslinking methodologies. Proteomics (2007) 0.95
Consomic strategies to localize genomic regions related to vascular reactivity in the Dahl salt-sensitive rat. Physiol Genomics (2006) 0.93
Relative quantification of peptide phosphorylation in a complex mixture using 18O labeling. Physiol Genomics (2007) 0.93
Zinc-finger nucleases: new strategies to target the rat genome. Clin Sci (Lond) (2010) 0.93
Introgression of the Brown Norway renin allele onto the Dahl salt-sensitive genetic background increases Cu/Zn SOD expression in cerebral arteries. Am J Hypertens (2011) 0.93
High throughput gene expression profiling: a molecular approach to integrative physiology. J Physiol (2004) 0.93
Visualize: a free and open source multifunction tool for proteomics data analysis. Proteomics (2011) 0.93
Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis. Physiol Genomics (2010) 0.92
Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol Genomics (2008) 0.92
High-salt diet depresses acetylcholine reactivity proximal to NOS activation in cerebral arteries. Am J Physiol Heart Circ Physiol (2002) 0.92
Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl salt-sensitive rat. Hypertension (2012) 0.92
Effects of high-salt diet on CYP450-4A omega-hydroxylase expression and active tone in mesenteric resistance arteries. Am J Physiol Heart Circ Physiol (2004) 0.92
Identification of hypertension susceptibility loci on rat chromosome 12. Hypertension (2012) 0.92
Prevalence of four putative periodontopathic bacteria in saliva of a group of Brazilian children with mixed dentition: 1-year longitudinal study. Int J Paediatr Dent (2007) 0.91
Recent acquisition of imprinting at the rodent Sfmbt2 locus correlates with insertion of a large block of miRNAs. BMC Genomics (2011) 0.90
Skeletal muscle arteriolar reactivity in SS.BN13 consomic rats and Dahl salt-sensitive rats. Hypertension (2003) 0.89
Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat. Am J Physiol Heart Circ Physiol (2004) 0.88
Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity. J Med Chem (2012) 0.88
Targeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease. Physiol Genomics (2013) 0.88
Chronic At1 receptor blockade alters the mechanisms mediating hypoxic dilation in middle cerebral arteries. J Cardiovasc Pharmacol (2005) 0.88
DeNovoID: a web-based tool for identifying peptides from sequence and mass tags deduced from de novo peptide sequencing by mass spectroscopy. Nucleic Acids Res (2005) 0.87
Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach. J Urol (2010) 0.87